497 related articles for article (PubMed ID: 11355001)
21. Cardenolide and bufadienolide ligands of the sodium pump. How they work together in NaCl sensitive hypertension.
Bagrov AY; Fedorova OV
Front Biosci; 2005 Sep; 10():2250-6. PubMed ID: 15970491
[TBL] [Abstract][Full Text] [Related]
22. Systemic hypertension: the roles of salt, vascular Na+/K+ ATPase and the endogenous glycosides, ouabain and marinobufagenin.
Hauck C; Frishman WH
Cardiol Rev; 2012; 20(3):130-8. PubMed ID: 22183064
[TBL] [Abstract][Full Text] [Related]
23. Involvement of Na(+), K(+)-ATPase and endogenous digitalis-like compounds in depressive disorders.
Goldstein I; Levy T; Galili D; Ovadia H; Yirmiya R; Rosen H; Lichtstein D
Biol Psychiatry; 2006 Sep; 60(5):491-9. PubMed ID: 16712803
[TBL] [Abstract][Full Text] [Related]
24. PST 2238 as an antihypertensive compound that antagonizes the effect of endogenous cardiac glycosides.
Winnicka K; Tomasiak M
Acta Pol Pharm; 2005; 62(1):75-9. PubMed ID: 16022498
[TBL] [Abstract][Full Text] [Related]
25. Targeting Ouabain- and Adducin-dependent mechanisms of hypertension and cardiovascular remodeling as a novel pharmacological approach.
Ferrari P; Ferrandi M; Valentini G; Manunta P; Bianchi G
Med Hypotheses; 2007; 68(6):1307-14. PubMed ID: 17097240
[TBL] [Abstract][Full Text] [Related]
26. Spin-labeled derivatives of cardiotonic steroids as tools for characterization of the extracellular entrance to the binding site on Na
Guo JH; Jiang RW; Andersen JL; Esmann M; Fedosova NU
FEBS J; 2018 Jun; 285(12):2292-2305. PubMed ID: 29688626
[TBL] [Abstract][Full Text] [Related]
27. The toxic effects on cardiac myocytes of tyledoside F, a cumulative neurotoxic cardiac glycoside isolated from Tylecodon grandiflorus.
van Rooyen JM; van der Walt JJ
Onderstepoort J Vet Res; 1990 Dec; 57(4):223-7. PubMed ID: 2293130
[TBL] [Abstract][Full Text] [Related]
28. Longer term effects of ouabain on the contractility of rat isolated cardiomyocytes and on the expression of Ca and Na regulating proteins.
Müller-Ehmsen J; Nickel J; Zobel C; Hirsch I; Bölck B; Brixius K; Schwinger RH
Basic Res Cardiol; 2003 Mar; 98(2):90-6. PubMed ID: 12607130
[TBL] [Abstract][Full Text] [Related]
29. Circulating bufodienolide and cardenolide sodium pump inhibitors in preeclampsia.
Lopatin DA; Ailamazian EK; Dmitrieva RI; Shpen VM; Fedorova OV; Doris PA; Bagrov AY
J Hypertens; 1999 Aug; 17(8):1179-87. PubMed ID: 10466474
[TBL] [Abstract][Full Text] [Related]
30. The physiological significance of the cardiotonic steroid/ouabain-binding site of the Na,K-ATPase.
Lingrel JB
Annu Rev Physiol; 2010; 72():395-412. PubMed ID: 20148682
[TBL] [Abstract][Full Text] [Related]
31. Hellebrin and its aglycone form hellebrigenin display similar in vitro growth inhibitory effects in cancer cells and binding profiles to the alpha subunits of the Na+/K+-ATPase.
Moreno Y Banuls L; Katz A; Miklos W; Cimmino A; Tal DM; Ainbinder E; Zehl M; Urban E; Evidente A; Kopp B; Berger W; Feron O; Karlish S; Kiss R
Mol Cancer; 2013 Apr; 12():33. PubMed ID: 23621895
[TBL] [Abstract][Full Text] [Related]
32. Endogenous cardiotonic steroids and differential patterns of sodium pump inhibition in NaCl-loaded salt-sensitive and normotensive rats.
Bagrov AY; Agalakova NI; Kashkin VA; Fedorova OV
Am J Hypertens; 2009 May; 22(5):559-63. PubMed ID: 19229192
[TBL] [Abstract][Full Text] [Related]
33. Time- and dose dependent actions of cardiotonic steroids on transcriptome and intracellular content of Na
Klimanova EA; Tverskoi AM; Koltsova SV; Sidorenko SV; Lopina OD; Tremblay J; Hamet P; Kapilevich LV; Orlov SN
Sci Rep; 2017 Mar; 7():45403. PubMed ID: 28345607
[TBL] [Abstract][Full Text] [Related]
34. Signalling pathways involving sodium pump stimulate endothelin-1 secretion and nitric oxide production in endothelial cells.
Scheiner-Bobis G; Eva A; Kirch U
Cell Mol Biol (Noisy-le-grand); 2006 Dec; 52(8):58-63. PubMed ID: 17535737
[TBL] [Abstract][Full Text] [Related]
35. [Inhibitory action of peruvoside and neriifolin on Na+, K(+)-ATPase].
Ye YX; Yang XR
Zhongguo Yao Li Xue Bao; 1990 Nov; 11(6):491-4. PubMed ID: 1966653
[TBL] [Abstract][Full Text] [Related]
36. Role of endosomal Na+-K+-ATPase and cardiac steroids in the regulation of endocytosis.
Feldmann T; Glukmann V; Medvenev E; Shpolansky U; Galili D; Lichtstein D; Rosen H
Am J Physiol Cell Physiol; 2007 Sep; 293(3):C885-96. PubMed ID: 17553933
[TBL] [Abstract][Full Text] [Related]
37. Determinants of human and mouse melanoma cell sensitivities to oleandrin.
Lin Y; Dubinsky WP; Ho DH; Felix E; Newman RA
J Exp Ther Oncol; 2008; 7(3):195-205. PubMed ID: 19066128
[TBL] [Abstract][Full Text] [Related]
38. Selective inhibition of the cellular sodium pump by emicymarin and 14ß anhydroxy bufadienolides.
Hilton PJ; McKinnon W; Gravett EC; Peron JM; Frampton CM; Nicholls MG; Lord G
Steroids; 2010 Dec; 75(13-14):1137-45. PubMed ID: 20688094
[TBL] [Abstract][Full Text] [Related]
39. Depth of the Steroid Core Location Determines the Mode of Na,K-ATPase Inhibition by Cardiotonic Steroids.
Tverskoi AM; Poluektov YM; Klimanova EA; Mitkevich VA; Makarov AA; Orlov SN; Petrushanko IY; Lopina OD
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948068
[TBL] [Abstract][Full Text] [Related]
40. Endogenous inhibitors of the Na,K pump.
Doris PA
Miner Electrolyte Metab; 1996; 22(5-6):303-10. PubMed ID: 8933501
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
